Improved antibacterial function of Rifampicin-loaded solid lipid nanoparticles on Brucella abortus

被引:42
作者
Ghaderkhani, Jalal [1 ]
Yousefimashouf, Rasoul [1 ]
Arabestani, Mohammadreza [1 ]
Roshanaei, Ghodratollah [2 ]
Asl, Sara Soleimani [3 ]
Abbasalipourkabir, Roghayeh [4 ]
机构
[1] Hamadan Univ Med Sci, Dept Microbiol, Hamadan, Iran
[2] Hamadan Univ Med Sci, Modeling Noncommunicable Dis Res Ctr, Sch Publ Hlth, Dept Biostat & Epidemiol, Hamadan, Iran
[3] Hamadan Univ Med Sci, Endometrium & Endometriosis Res Ctr, Hamadan, Iran
[4] Hamadan Univ Med Sci, Dept Biochem, Hamadan, Iran
关键词
Solid lipid nanoparticles; rifampicin; antibacterial activity; Brucella abortus; IN-VITRO; DELIVERY-SYSTEMS; STEARIC-ACID; FORMULATION; CRYSTALLINITY; ENCAPSULATION; STREPTOMYCIN; MACROPHAGES; MELITENSIS; STABILITY;
D O I
10.1080/21691401.2019.1593858
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The objective of this study was to assess the antibacterial activity of Rifampicin-loaded solid lipid nanoparticles on Brucella abortus 544. Rifampicin-loaded solid lipid nanoparticles were prepared by a modified microemulsion/sonication method and characterized. The results showed the average size about 319.7 nm, PI about 0.20 and zeta potential about 18.4 mv, encapsulation efficacy and drug-loading were equal to 95.78 and 34.2%, respectively, with a spherical shape. Drug release lasted for 5 days. The antibacterial activity was statistically significant with rho < .05 in bacterial and cell culture media compared to free Rifampicin. It can be concluded that solid lipid nanoparticles can be considered as a promising delivery system for improving the antibacterial activity of Rifampicin against Brucella abortus.
引用
收藏
页码:1181 / 1193
页数:13
相关论文
共 50 条
[1]  
Aboutaleb E, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-33
[2]   A preliminary investigation to group disparate batches of licit and illicit diazepam tablets using differential scanning calorimetry [J].
Bibi, S. ;
Bremner, D. H. ;
Macdougall-Heasman, M. ;
Reid, R. ;
Simpson, K. ;
Tough, A. ;
Waddell, S. ;
Stewart, I. J. ;
Matthews, K. H. .
ANALYTICAL METHODS, 2015, 7 (20) :8597-8604
[3]  
Bodaghabadi Narges, 2018, Iranian Biomedical Journal, V22, P275, DOI 10.22034/ibj.22.4.275
[4]   Delivery systems to increase the selectivity of antibiotics in phagocytic cells [J].
Briones, Elsa ;
Colino, Clara Isabel ;
Lanao, Jose M. .
JOURNAL OF CONTROLLED RELEASE, 2008, 125 (03) :210-227
[5]   In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel [J].
Chen, DB ;
Yang, TZ ;
Lu, WL ;
Zhang, Q .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (11) :1444-1447
[6]   Pathogenesis and Immunobiology of Brucellosis Review of Brucella-Host Interactions [J].
de Figueiredo, Paul ;
Ficht, Thomas A. ;
Rice-Ficht, Allison ;
Rossetti, Carlos A. ;
Adams, L. Garry .
AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (06) :1505-1517
[7]   Development and evaluation of taste-masked dry suspension of cefuroxime axetil for enhancement of oral bioavailability [J].
Du, Yuqian ;
Zhai, Yinglei ;
Zhang, Juhong ;
Wu, Chunnuan ;
Luo, Cong ;
Sun, Jin ;
He, Zhonggui .
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 8 (05) :287-294
[8]   Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants/stabilizers on physicochemical properties of nanoparticles [J].
Ebrahimi, Hossein Ali ;
Javadzadeh, Yousef ;
Hamidi, Mehrdad ;
Jalali, Mohammad Barzegar .
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 23
[9]  
Ekambaram P, 2011, J YOUNG PHARM, V3, P216, DOI [10.4103/0975-1483.83765, 10.410310975-1483.83765]
[10]  
Farazi A. A., 2014, Arak Medical University Journal, V17, P47